GCP compliance

HALIFAX, NOVA SCOTIA | December 30, 2025 — MedMira Inc. reported its first-quarter FY2026 results, highlighting a pivotal period...

NEW YORK | December 31, 2025 — Axsome Therapeutics announced it has received formal FDA pre–New Drug Application (Pre-NDA)...

Florham Park, New Jersey | December 22, 2025 — Celularity Inc., a regenerative and cellular medicine company focused on...

Gothenburg, Sweden | December 23, 2025 — IRLAB Therapeutics AB announced that it has received regulatory and ethical approvals...

TURKU, Finland; LONDON, United Kingdom — December 22, 2025 — Faron Pharmaceuticals Ltd, a clinical-stage biopharmaceutical company, has announced...

CANTANHEDE, Portugal — December 22, 2025 — Mondego Bio has announced the formal selection of ZE00-0388, a highly selective...